-
OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS
Feb 25, 2026, 14:42 PM -
EVALUATING PATIENT PREFERENCES FOR COPD MAINTENANCE TREATMENT DELIVERY DEVICES: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:42 PM -
DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS
Feb 25, 2026, 14:42 PM -
REAL-WORLD INSIGHTS INTO OBESITY PATHWAYS, PRESCRIBING, PATIENT COMPLEXITY, AND CARE GAPS THROUGH PRIMARY CARE DATABASES
Feb 25, 2026, 14:42 PM -
AUTOMATING SYSTEMATIC LITERATURE REVIEWS (SLR) IN ONCOLOGY: DEVELOPMENT AND PERFORMANCE OF A PROPRIETARY DATA MANAGEMENT AND MAINTENANCE SYSTEM (DMS)
Feb 25, 2026, 14:42 PM -
THE ECONOMIC COST OF PREVENTABLE BLINDNESS: PROJECTING THE SOCIOECONOMIC BURDEN OF DIABETIC MACULAR EDEMA IN CHILE (2017-2032)
Feb 25, 2026, 14:42 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Feb 25, 2026, 14:42 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Feb 25, 2026, 14:42 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:42 PM -
REAL-WORLD TREATMENT PATTERNS AND EFFICACY OF FIRST-LINE THERAPIES IN PATIENTS WITH MET EXON 14 SKIPPING-MUTATED NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:42 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Feb 25, 2026, 14:42 PM -
GEOSPATIAL EQUITY AND ECONOMIC IMPLICATIONS OF HEALTH DEVELOPMENT OFFICES IN HUNGARY
Feb 25, 2026, 14:42 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Feb 25, 2026, 14:42 PM -
USE ARTIFICIAL INTELLIGENCE TO PREDICT REGULATORY APPROVAL BASED ON PHASE III ONCOLOGY CLINICAL TRIAL PUBLICATIONS
Feb 25, 2026, 14:42 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Feb 25, 2026, 14:42 PM -
THE HERCULES STUDY: METHODS AND RATIONALE OF ASSESSING THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS LIVING WITH EARLY-STAGE CHRONIC KIDNEY DISEASE AND THEIR CARERS IN THE US
Feb 25, 2026, 14:42 PM -
LEVERAGING AI-DRIVEN NATURAL LANGUAGE PROCESSING TO ENHANCE SYMPTOM CAPTURE IN PRIMARY BILIARY CHOLANGITIS (PBC) AND PRIMARY SCLEROSING CHOLANGITIS (PSC)
Feb 25, 2026, 14:42 PM -
EFFECT OF STRUCTURED COACHING AND EDUCATION ON GLYCEMIC AND PATIENT-REPORTED OUTCOMES AMONG ADULTS INITIATING CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED STUDY
Feb 25, 2026, 14:41 PM -
USING THE DELPHI METHOD TO IDENTIFY EVIDENCE GAPS IN SUPPORT OF HTA SUBMISSIONS FOR RARE PEDIATRIC CONDITIONS: A CASE STUDY IN NON-DYSTROPHIC MYOTONIAS
Feb 25, 2026, 14:41 PM -
WILLINGNESS TO TRADE EFFECTIVENESS FOR OTHER CONTRACEPTIVE FEATURES: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:41 PM
